{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:17:52Z","timestamp":1792642672490,"version":"4.5.0"},"reference-count":109,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>One of the major organs in the body with multiple functions is the liver. It plays a central role in the transformation of macronutrients and clearance of chemicals and drugs. The serum biomarkers often used to indicate liver damage are not specifically for drug-induced liver injury (DILI) or liver injury caused by other xenobiotics, nor for viral infection. In this case, microRNAs (miRNAs) could play an exciting role as biomarkers of specific liver damage. In this review, we aimed to update the current literature on liver damage induced by drugs, as acute conditions and viral infections mediated by the hepatitis B virus (HBV) linked these two conditions to advanced research, with a focus on microRNAs as early biomarkers for liver damage. The undoubtable evidence that circulating miR-122 could be used as a human biomarker of DILI came from several studies in which a strong increase of it was linked with the status of liver function. In infancy, there is the possibility of an early miRNA detection for hepatitis B virus infection, but there are a lack of solid models for studying the HVB molecular mechanism of infection in detail, even if miRNAs do hold unrealized potential as biomarkers for early detection of hepatitis B virus infection mediated by HBV.<\/jats:p>","DOI":"10.3390\/cimb45010006","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T07:33:33Z","timestamp":1672126413000},"page":"78-91","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Liver Damage and microRNAs: An Update"],"prefix":"10.3390","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0562-0597","authenticated-orcid":false,"given":"Erika","family":"Cione","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy"},{"name":"Galascreen Laboratories, University of Calabria, 87036 Rende, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5161-057X","authenticated-orcid":false,"given":"Diana Marisol","family":"Abrego Guandique","sequence":"additional","affiliation":[{"name":"Galascreen Laboratories, University of Calabria, 87036 Rende, Italy"},{"name":"Department of Health Sciences, University of Magna Graecia Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Caroleo","sequence":"additional","affiliation":[{"name":"Galascreen Laboratories, University of Calabria, 87036 Rende, Italy"},{"name":"Department of Health Sciences, University of Magna Graecia Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Luciani","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit Annunziata Hospital, 87100 Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Colosimo","sequence":"additional","affiliation":[{"name":"Microbiology Unit Pugliese Ciaccio Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1668-7690","authenticated-orcid":false,"given":"Roberto","family":"Cannataro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy"},{"name":"Galascreen Laboratories, University of Calabria, 87036 Rende, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders: Report of an International Consensus Meeting","volume":"11","year":"1990","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/106002809502900910","article-title":"Application of International Consensus Meeting Criteria for Classifying Drug-Induced Liver Disorders","volume":"29","author":"Habra","year":"1995","journal-title":"Ann. Pharmacother."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Orze\u0142-Gajowik, K., Milewski, K., and Zieli\u0144ska, M. (2021). Insight into microRNAs-Mediated Communication between Liver and Brain: A Possible Approach for Understanding Acute Liver Failure?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010224"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/hep.22656","article-title":"Hepatic function is preserved in the absence of mature microRNAs","volume":"49","author":"Hand","year":"2009","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Cannataro, R., Caroleo, M.C., Fazio, A., La Torre, C., Plastina, P., Gallelli, L., Lauria, G., and Cione, E. (2019). Ketogenic Diet and microRNAs Linked to Antioxidant Biochemical Homeostasis. Antioxidants, 8.","DOI":"10.3390\/antiox8080269"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Cannataro, R., Carbone, L., Petro, J.L., Cione, E., Vargas, S., Angulo, H., Forero, D.A., Odriozola-Mart\u00ednez, A., Kreider, R.B., and Bonilla, D.A. (2021). Sarcopenia: Etiology, Nutritional Approaches, and miRNAs. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189724"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Cione, E., Cannataro, R., Gallelli, L., De Sarro, G., and Caroleo, M.C. (2021). Exosome microRNAs in Metabolic Syndrome as Tools for the Early Monitoring of Diabetes and Possible Therapeutic Options. Pharmaceuticals, 14.","DOI":"10.3390\/ph14121257"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of Tissue-Specific MicroRNAs from Mouse","volume":"12","author":"Rauhut","year":"2002","journal-title":"Curr. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1101\/gad.1781009","article-title":"Integration of microRNA miR-122 in hepatic circadian gene expression","volume":"23","author":"Gatfield","year":"2009","journal-title":"Genes Dev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1172\/JCI44883","article-title":"The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice","volume":"121","author":"Castoldi","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2006478118","DOI":"10.1073\/pnas.2006478118","article-title":"Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosis","volume":"118","author":"Price","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 Contributes to the Regulation of Cholesterol Homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/JME-20-0324","article-title":"miR-23a\/b-3p promotes hepatic lipid accumulation by regulating Srebp-1c and Fas","volume":"68","author":"Li","year":"2021","journal-title":"J. Mol. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.cellsig.2013.03.003","article-title":"MicroRNA-1 and microRNA-206 suppress LXR\u03b1-induced lipogenesis in hepatocytes","volume":"25","author":"Zhong","year":"2013","journal-title":"Cell. Signal."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s00125-012-2539-8","article-title":"Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity","volume":"55","author":"Zhou","year":"2012","journal-title":"Diabetologia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100179","DOI":"10.1016\/j.jhepr.2020.100179","article-title":"Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor","volume":"2","author":"Wang","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3945\/jn.112.160341","article-title":"Maternal Low-Protein Diet Induces Gender-Dependent Changes in Epigenetic Regulation of the Glucose-6-Phosphatase Gene in Newborn Piglet Liver","volume":"142","author":"Jia","year":"2012","journal-title":"J. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11602","DOI":"10.1038\/srep11602","article-title":"MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes","volume":"5","author":"Dou","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1053\/j.gastro.2021.08.030","article-title":"Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity","volume":"161","author":"Azzimato","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cell.2011.08.033","article-title":"The Lin28\/let-7 Axis Regulates Glucose Metabolism","volume":"147","author":"Zhu","year":"2011","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/liv.12239","article-title":"Overexpression of miR-122 promotes the hepatic differentiation and maturation of mouse ESCs through a miR-122\/FoxA1\/HNF4a-positive feedback loop","volume":"34","author":"Deng","year":"2014","journal-title":"Liver Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"115389","DOI":"10.1016\/j.taap.2020.115389","article-title":"Variation in the expression of cytochrome P450-related miRNAs and transcriptional factors in human livers: Correlation with cytochrome P450 gene phenotypes","volume":"412","author":"Zhang","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.1074\/jbc.M709382200","article-title":"Post-transcriptional Regulation of Human Pregnane X Receptor by Micro-RNA Affects the Expression of Cytochrome P450 3A4","volume":"283","author":"Takagi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bcp.2009.11.015","article-title":"Human CYP2E1 is regulated by miR-378","volume":"79","author":"Mohri","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/mol.112.078386","article-title":"Human CYP2C8 Is Post-Transcriptionally Regulated by MicroRNAs 103 and 107 in Human Liver","volume":"82","author":"Zhang","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1074\/jbc.M109.085431","article-title":"MicroRNAs Regulate Human Hepatocyte Nuclear Factor 4\u03b1, Modulating the Expression of Metabolic Enzymes and Cell Cycle","volume":"285","author":"Takagi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Roh, Y.J., Kim, Y., Lee, J.S., Oh, J.H., Lee, S.M., Yoon, E.L., Lee, S.R., and Jun, D.W. (2022). Regulation of Hepatocyte Nuclear Factor 4\u03b1 Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease. Life, 12.","DOI":"10.3390\/life12111682"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s11095-013-1200-7","article-title":"Regulation of Cytochrome b 5 Expression by miR-223 in Human Liver: Effects on Cytochrome P450 Activities","volume":"31","author":"Takahashi","year":"2014","journal-title":"Pharm. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: A French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, Presentation, and Outcomes in Patients with Drug-Induced Liver Injury in the General Population of Iceland","volume":"144","author":"Bergmann","year":"2013","journal-title":"Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1572-0241.2006.01019.x","article-title":"Etiology of new-onset jaundice: How often is it caused by idiosyncratic drug-induced liver injury in the United States?","volume":"102","author":"Vuppalanchi","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Druginduced acute liver failure: Results of a U.S. multicenter, prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2796.2007.01818.x","article-title":"Acute liver failure in Sweden: Etiology and outcome","volume":"262","author":"Wei","year":"2007","journal-title":"J. Intern. Med."},{"key":"ref_35","first-page":"116","article-title":"Ketogenic Diet Acts on Body Remodeling and MicroRNAs Expression Profile","volume":"8","author":"Cannataro","year":"2019","journal-title":"MicroRNA (Shariqah, United Arab Emirates)"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3892\/etm.2016.3627","article-title":"Clinical characteristics of drug-induced liver injury and related risk factors","volume":"12","author":"Lu","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrendo.2010.96","article-title":"Propylthiouracil use associated with severe hepatotoxicity in children","volume":"6","author":"Koch","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: An update","volume":"94","author":"Cortes","year":"2020","journal-title":"Arch. Toxicol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, Clinical Features, and Outcomes from a Prospective Study of Drug-Induced Liver Injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40262-021-01001-5","article-title":"Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes","volume":"60","author":"Song","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cld.2012.03.002","article-title":"Drug-Induced Liver Disease","volume":"16","author":"Davern","year":"2012","journal-title":"Clin. Liver Dis."},{"key":"ref_43","unstructured":"Zimmerman, H.J. (1999). Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver, 2nd ed, Lippincott Williams & Wilkins."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and Outcomes of 899 Patients with Drug-Induced Liver Injury: The DILIN Prospective Study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.14309\/ajg.0000000000000398","article-title":"Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors","volume":"115","author":"Miller","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.disamonth.2013.11.002","article-title":"Drug-induced liver disease: Primer for the primary care physician","volume":"60","author":"Marks","year":"2014","journal-title":"Disease-A-Month"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1208\/aapsj080106","article-title":"Mechanisms of drug-induced liver injury","volume":"8","author":"Holt","year":"2006","journal-title":"AAPS J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cld.2013.07.002","article-title":"Mechanisms of Drug-induced Liver Injury","volume":"17","author":"Yuan","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kaplowitz, N., and DeLeve, L. (2003). Immunological mechanisms in liver injury. Drug-Induced Liver Disease, CRC Press.","DOI":"10.1201\/b15279"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","article-title":"Drug-induced liver injury","volume":"30","author":"Abboud","year":"2007","journal-title":"Drug Saf."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/SMJ.0000000000000059","article-title":"Nitrofurantoin-Induced Hepatotoxicity: A Rare Yet Serious Complication","volume":"107","author":"Sakaan","year":"2014","journal-title":"South. Med. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_54","first-page":"1","article-title":"Acetaminophen hepatotoxicity: NO to the rescue","volume":"143","author":"Wallace","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00002018-200124070-00003","article-title":"Management of paracetamol overdose: Current controversies","volume":"24","author":"Kozer","year":"2001","journal-title":"Drug Saf."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/hrt.59.6.690","article-title":"Acute hepatitis after parenteral amiodarone administration","volume":"59","author":"Pye","year":"1988","journal-title":"Heart"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0002-9343(92)90689-9","article-title":"Hepatotoxicity associated with sustained-release niacin","volume":"93","author":"Dalton","year":"1992","journal-title":"Am. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/liv.13032","article-title":"Liver injury from nonsteroidal anti-inflammatory drugs in the United States","volume":"36","author":"Schmeltzer","year":"2016","journal-title":"Liver Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"Kosinski","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_62","first-page":"3596","article-title":"Identification and Characterization of Fenofibrate-Induced Liver Injury","volume":"62","author":"Ahmad","year":"2017","journal-title":"Am. J. Dig. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.cgh.2014.11.036","article-title":"Identification and Characterization of Cefazolin-Induced Liver Injury","volume":"13","author":"Alqahtani","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jhep.2018.08.004","article-title":"The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine","volume":"69","author":"Fontana","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_65","first-page":"1415","article-title":"Clinical and Histological Features of Idiosyncratic Acute Liver Injury Caused by Temozolomide","volume":"58","author":"Grant","year":"2013","journal-title":"Am. J. Dig. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2011.02.019","article-title":"Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury","volume":"9","author":"Orman","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2014.07.054","article-title":"Clinical and Histologic Features of Azithromycin-Induced Liver Injury","volume":"13","author":"Martinez","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cgh.2012.12.025","article-title":"Liver Injury From Tumor Necrosis Factor-\u03b1 Antagonists: Analysis of Thirty-four Cases","volume":"11","author":"Ghabril","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.27317","article-title":"Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network","volume":"60","author":"Navarro","year":"2014","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s40264-016-0428-7","article-title":"Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK\u00ae Weight Loss Products: Results from the DILIN Prospective Study","volume":"39","author":"Zheng","year":"2016","journal-title":"Drug Saf."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1373\/clinchem.2010.147850","article-title":"Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases","volume":"56","author":"Zhang","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.3748\/wjg.v18.i22.2798","article-title":"Plasma microRNA profiles distinguish lethal injury in acetaminophen toxicity: A research study","volume":"18","author":"Ward","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2217\/bmm.13.9","article-title":"Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury","volume":"7","author":"Shi","year":"2013","journal-title":"Biomarkers Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Yamaura, Y., Nakajima, M., Takagi, S., Fukami, T., Tsuneyama, K., and Yokoi, T. (2012). Plasma MicroRNA Profiles in Rat Models of Hepatocellular Injury, Cholestasis, and Steatosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030250"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Su, Y.-W., Chen, X., Jiang, Z.-Z., Wang, T., Wang, C., Zhang, Y., Wen, J., Xue, M., Zhu, D., and Zhang, Y. (2012). A Panel of Serum MicroRNAs as Specific Biomarkers for Diagnosis of Compound- and Herb-Induced Liver Injury in Rats. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037395"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/0192623312464436","article-title":"Evaluation of miR-122 and Other Biomarkers in Distinct Acute Liver Injury in Rats","volume":"41","author":"Starckx","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.24538","article-title":"Circulating microRNAs as potential markers of human drug-induced liver injury","volume":"54","author":"Lewis","year":"2011","journal-title":"Hepatology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.taap.2012.01.009","article-title":"Omics analysis of low dose acetaminophen intake demonstrates novel response pathways in humans","volume":"259","author":"Jetten","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.26294","article-title":"Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital","volume":"58","author":"Antoine","year":"2013","journal-title":"Hepatology"},{"key":"ref_83","first-page":"1428","article-title":"Circulating microRNA-122 as a potential biomarker for liver injury","volume":"5","author":"Ding","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: The virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJM197611252952206","article-title":"The virus of hepatitis type B","volume":"295","author":"Robinson","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.1840090226","article-title":"Compact organization of the hepatitis B virus genome","volume":"9","author":"Miller","year":"1989","journal-title":"Hepatology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/jvi.52.2.396-402.1984","article-title":"Large surface proteins of hepatitis B virus containing the pre-s sequence","volume":"52","author":"Heermann","year":"1984","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/0168-8278(91)90033-8","article-title":"Hepatitis B surface proteins","volume":"13","author":"Gerlich","year":"1991","journal-title":"J. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e27941","DOI":"10.1097\/MD.0000000000027941","article-title":"Distribution of hepatitis B virus genotypes and subgenotypes: A meta-analysis","volume":"100","author":"Liu","year":"2021","journal-title":"Medicine"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B Virus Biology","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/jvi.64.2.613-620.1990","article-title":"Mutational analysis of the hepatitis B virus P gene product: Domain structure and RNase H activity","volume":"64","author":"Radziwill","year":"1990","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.bi.56.070187.003251","article-title":"The molecular biology of the hepatitis B viruses","volume":"56","author":"Ganem","year":"1987","journal-title":"Annu. Rev. Biochem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/oxfordjournals.bmb.a072403","article-title":"Immunology of hepatitis B virus infection","volume":"46","author":"Alexander","year":"1990","journal-title":"Br. Med Bull."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00000441-197509000-00001","article-title":"Immunological aspects of hepatitis B virus infection","volume":"270","author":"Edgington","year":"1975","journal-title":"Am. J. Med Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-8278(88)80503-8","article-title":"Cellular immune response to hepatitis B virus antigens: An overview","volume":"7","author":"Ferrari","year":"1988","journal-title":"J. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0882-4010(89)90073-9","article-title":"Hepatitis B virus structure and biology","volume":"6","author":"Chisari","year":"1989","journal-title":"Microb. Pathog."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4103\/0366-6999.237394","article-title":"Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B","volume":"131","author":"Li","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_99","unstructured":"Moroni, M., Esposito, R., and De Lalla, F. (2003). Malattie Infettive, Masson."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Chan","year":"2014","journal-title":"Lancet"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2013.08.035","article-title":"Hepatitis B virus-induced hepatocellular carcinoma","volume":"345","author":"Xu","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e01919-16","DOI":"10.1128\/JVI.01919-16","article-title":"Hepatitis B Virus-Encoded MicroRNA Controls Viral Replication","volume":"91","author":"Yang","year":"2017","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3748\/wjg.v26.i11.1113","article-title":"Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis","volume":"26","author":"Iacob","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/infdis\/jix140","article-title":"Plasma MicroRNA Levels Are Associated with Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients","volume":"215","author":"Jansen","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12985-018-0982-y","article-title":"Pretreatment microRNA levels can predict HBsAg clearance in CHB patients treated with pegylated interferon \u03b1-2a","volume":"15","author":"Yang","year":"2018","journal-title":"Virol. J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3851\/IMP2401","article-title":"Plasma Microrna Profile as a Predictor of Early Virological Response to Interferon Treatment in Chronic Hepatitis B Patients","volume":"17","author":"Zhang","year":"2012","journal-title":"Antivir. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e110782","DOI":"10.1371\/journal.pone.0110782","article-title":"A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection","volume":"9","author":"Brunetto","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"15658","DOI":"10.1038\/s41598-017-15594-0","article-title":"Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients","volume":"7","author":"Liang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/45\/1\/6\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:49:11Z","timestamp":1760147351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/45\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["cimb45010006"],"URL":"https:\/\/doi.org\/10.3390\/cimb45010006","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]}}}